| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Feb, 2026 | Feb, 2026 | Feb, 2026 |
| Sales | 2,700 | 2,740 | 0 | 0 | 0 |
| Sales Growth | -1.46% | unch | unch | unch | unch |
| Net Income | -76,290 | -46,020 | 0 | 0 | 0 |
| Net Income Growth | -65.78% | unch | unch | unch | unch |
Anteris Technologies Global Corp
(AVR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Anteris Technologies Global Corp. is involved in designing, developing and commercializing cutting-edge medical devices to restore healthy heart function. The company's lead product includes DurAVR(R). Anteris Technologies Global Corp. is based in BRISBANE, Australia.
Fiscal Year End Date: 12/31